Biotechnology

Techseriesinsight > Blog > News > Biotechnology

July 7, 2025
PRNewswire
Biotechnology, News

VIOME COLLABORATES WITH MICROSOFT TO DELIVER PREVENTIVE HEALTHCARE WITH ONE OF WORLD’S LARGEST RNA DATASETS

Viome Life Sciences, a leader in AI-powered, RNA-based molecular diagnostics and personalized nutrition, today announced a collaboration with Microsoft to accelerate the next generation of preventive and personalized healthcare. As part...

July 7, 2025
PRNewswire
Biotechnology, News

Cyrex Launches BiomeBurden™ for Immune Sensitivity Testing of Microbial, Yeast and Mold Triggers

Cyrex Laboratories, a clinical laboratory specializing in functional immunology and autoimmunity, today announced the launch of BiomeBurden™, its newest innovation in gut biome testing. This advanced 3-panel testing approach is designed to...

July 3, 2025
PRNewswire
Biotechnology, News

Esaote presents at ECVS 2025 the new generation of veterinary MRI, Vet -MR Grande ELITE

Esaote, a leading company in the field of medical diagnostic imaging, presents the new Vet -MR Grande ELITE, the next generation of veterinary MRI at the ECVS 2025, the Annual scientific meeting...

July 3, 2025
PRNewswire
Biotechnology, News

Novogene Europe Expands Sequencing Capabilities with Fifth NovaSeq X Plus System in Europe

Novogene Europe announces the installation of its fifth Illumina NovaSeq X Plus sequencing system, expanding high-throughput sequencing capacity to meet surging European demand. This strategic enhancement solidifies Novogene’s position...

July 3, 2025
PRNewswire
Biotechnology, News

MOTE Therapeutics Taps MaryJane Rafii as Chief Investment & Business Officer to Drive Global Growth of RNA Delivery Platform

MOTE Therapeutics (referred as MOTE), a seed-stage biotech developing targeted RNA delivery solutions, announced the appointment of MaryJane Rafii, PhD, MBA, as Chief Investment and Business Officer. The move comes...

July 1, 2025
PRNewswire
Biotechnology, Healthcare, News

Trevi Therapeutics to Attend Leerink Partners Therapeutics Forum: I&I and Metabolism

Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and...

July 1, 2025
Business Wire
Biotechnology, Healthcare, News

Vertex’s ALYFTREK® Approved by European Commission

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for ALYFTREK® (deutivacaftor/tezacaftor/vanzacaftor)for the treatment of people with cystic fibrosis (CF) ages 6 years and older who have...

July 1, 2025
Business Wire
Artificial Intelligence, Biotechnology, Healthcare, News

IQVIA to Announce Second-Quarter 2025 Results on July 22, 2025

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, will announce its second-quarter...

June 30, 2025
PRNewswire
Biotechnology, News

Piramal Pharma Solutions Breaks Ground on $90M Expansion Plan

Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. (NSE: PPLPHARMA) (BSE: 543635), recently announced a $90M investment plan to expand two...

June 27, 2025
PRNewswire
Biotechnology, News

Zentiva calls for Pause – Repair – Relaunch of the Urban Wastewater Treatment Directive (UWWTD)

As the EU adapts to global geopolitical tensions and renews its focus on simplifying legislation, Medicines for Europe convened policymakers, industry leaders, and partners for its annual meeting in Brussels. The conference...